Senior Director, Corporate Development

The Terra Power Isotopes® (TPI™) division has been established to pursue medical isotopes development--advancing nuclear science for significant human health benefits. We seek to support revolutionary radio therapies for treatments of various cancers through the supply of radioisotopes. Terra Power currently has unique access to a supply of thorium for the long-term production of actinium-225 in the growing alpha therapy market and intends to expand into other nuclear related medical treatments.

The Terra Power Isotopes program is an integral part of the Washington State based Terra Power team, a company working to raise living standards globally. In 2006, the company originated with Bill Gates and a group of like-minded visionaries who evaluated the fundamental challenges to raising living standards around the world. Terra Power’s mission is to be a world leader in new nuclear technologies, while developing innovators and future leaders in the nuclear field.

TPI is seeking to hire highly motivated and forward-thinking professionals who are interested in focusing on advanced radiopharmaceutical applications and influencing change within nuclear medicine. Terra Power is an Equal Opportunity Employer. We do not discriminate in hiring on the basis of sex, gender identity, sexual orientation, race, color, religious creed, national origin, physical or mental disability, protected veteran status, or any other characteristic protected by federal, state, or local law.

Senior Director, Corporate Development

The Senior Director of Corporate Development, reporting to the Vice President of Commercial and Strategy, owns the long-horizon growth architecture of Terra Power Isotopes across mergers and acquisitions, partnerships, alternative revenue structures, and capital planning. The role sits apart from day-to-day sales and account management, and exists to determine which organizations TPI should be working with, on what terms, and how the business is financed to reach the resulting position.

The successful candidate will bring transaction experience within the radiopharmaceutical or nuclear medicine industry, the financial depth to value and structure deals independently, and comfort operating as a senior individual contributor in a company scaling rapidly through a capital intensive build.

Responsibilities

Mergers, Acquisitions, and Partnerships

• Originate, screen, and prioritize acquisition, merger, joint venture, and partnership opportunities against TPI’s strategic position and capital constraints
• Build and defend valuation models, including discounted cash flow, comparable company and transaction analysis, and scenario work, to a standard that withstands external advisor and Board scrutiny
• Lead financial and commercial diligence, integrating technical, legal, quality, and regulatory work streams into a single view of value and risk
• Structure deal transaction terms, governance, and support negotiation through to signing
• Prepare Board-level transaction materials presenting risks, rewards, and alternatives across scenarios without slant toward a preferred outcome
• Develop post-close integration plans, including synergy definition, sequencing, and tracking against the deal case
• Design and evaluate alternatives to unit-priced supply
• Model the trade-off between near-term realized price and long-term participation in customer product value
• Assess counter party creditworthiness, clinical probability of success, and dilution exposure where non-cash consideration is contemplated

Capital Planning and Financing

• Develop and maintain the long-range financial plan linking production capacity expansion, revenue ramp, and capital requirements
• Evaluate equity, debt, project finance, government, and strategic-partner funding…